about
[Physiopathology of idiopathic thrombopenic purpura].[Treatment of immune thrombocytopenia: a retrospective study of 40 patients].[Pathophysiology of immune thrombocytopenia].Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience.Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsA case-control study to assess the risk of immune thrombocytopenia associated with vaccines.Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia.Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia.Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanismMyeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cellsInhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice.Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.Killer dendritic cells and their potential for cancer immunotherapy.Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology.The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced toleranceGood syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications.Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia.Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells.Cytotoxic dendritic cells generated from cancer patients.[Severe thrombocytopenia and mild leucopenia associated with deferasirox therapy].A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines.Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.Is TNF-α really involved in giant cell arteritis pathogenesis?Reply: To PMID 22833233.[Excessive sweating related to hydromorphone].Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect.Stroke associated with giant cell arteritis: a population-based study.Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model.Efficacy of colchicine alone or in combination with vinca alkaloids in severe corticoid-resistant thrombocytopenic purpura: six cases.Liver X Receptor–Mediated Induction of Cholesteryl Ester Transfer Protein Expression Is Selectively Impaired in Inflammatory Macrophages
P50
Q33386864-142C8B43-BE6D-4D53-925C-6D4BB80B7120Q33389229-D414E6A0-FC29-4909-9CD3-A599C11BA7FBQ33390212-C060B673-F1BD-413B-9710-FB7F0FCDBB32Q33395464-5A220364-F0D6-4253-B82F-45A0F6182C62Q33396902-A3BF382B-1660-4B7C-AB43-C22F65E3401AQ33397525-B4095800-FA62-4FE4-8062-5092BFD7833EQ33404040-9CA61F5F-A109-41AC-8202-42F8D354EBD6Q33408621-5B919ED2-DCEC-4C17-A8DF-3A0782B97DC2Q33409902-81C11C91-4733-48DA-A9D6-A21D15593D81Q33417711-0C98D662-210D-4ABA-B12B-D0E29B761A88Q33423897-36FC748F-766B-43F6-9302-516782BFAC44Q34076409-9103A28B-6763-46DB-A084-90857C98C0F3Q34667551-7E34776B-9F2C-412F-A564-4BB5ECB4986BQ35814814-6216C84D-6080-4CF1-ADBF-E1D21A6573C8Q36332711-3B9B9B44-A6AC-4ED5-ADB2-2EBEC4826309Q37305409-82B0254F-A3BD-438C-BC7D-726AEC7EBD1AQ37494817-24E33FC2-ACCF-4D03-91F5-C782D9F4DA3BQ37556082-E68CE93A-467A-4CF7-8DCC-4CDE5B96087DQ37805238-226D5203-9741-41EB-9502-C45F508A2174Q37959968-034EC693-448D-4832-9C4E-B73CA94E96C3Q41365452-6274799B-A42F-48E0-9BC3-5D11640C43F3Q41676109-C5B4B36B-1606-4069-A572-A9ABAFEE0DC8Q41704758-0053F54E-F47D-4596-86AD-FE7B86DBD4B7Q42214202-DBA913A3-8E25-426E-960B-F0715B179AC5Q42873004-85FC2561-0F85-49B9-B812-EF79C5A078BDQ43152008-8B74FDAB-489F-4412-B427-C4B4CE59FD74Q43444886-3244F769-995C-4F69-B455-EB1CE2ABBF81Q43446243-519852DA-F678-4CD1-923B-C7EAD60F17EDQ43511814-CE9AA36D-EBA4-4411-B4B9-E0A293701466Q43513605-6EDFB883-E9DB-4395-BB24-4B617F373329Q44678307-41D472F3-A41E-4D06-A4E7-DEC9207DE00AQ44713607-993BE74C-8F69-40BA-AFA3-5B266D98CE12Q44736294-4268B01C-0B72-4BDB-B099-0762CFAA04AAQ45280434-1984C40B-5E04-4352-9EB9-EFB9C8FE8259Q48412307-830F7C67-7444-4435-A15A-63F6CA95900EQ50755207-F36DD770-1060-4978-955E-2F921965EF6FQ51267642-4DE9D2AF-6ECC-4351-8008-12FA9FCCD480Q53334056-A21FA03A-CF0D-4184-8DD5-F30BD268AEBFQ54066621-8B34343A-4ACA-4F1D-9E59-F63837230CFEQ57220022-9BB9FE2F-DD0E-4AF8-B5D4-7E387A026BFA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bernard Bonnotte
@ast
Bernard Bonnotte
@en
Bernard Bonnotte
@es
Bernard Bonnotte
@nl
type
label
Bernard Bonnotte
@ast
Bernard Bonnotte
@en
Bernard Bonnotte
@es
Bernard Bonnotte
@nl
prefLabel
Bernard Bonnotte
@ast
Bernard Bonnotte
@en
Bernard Bonnotte
@es
Bernard Bonnotte
@nl
P106
P1153
7003765102
P21
P31
P496
0000-0002-1098-4598